Combining Functional and Anatomical Imaging for Orthopaedic Diagnosis
SPECT-CT vs Planar Bone Scan vs PET-CT
Planar bone scan: 2D, whole-body, sensitive but poor anatomical localisation, lowest dose
SPECT-CT: 3D, regional, better contrast resolution, precise anatomical localisation, moderate dose
PET-CT: 3D, whole-body or regional, superior resolution and specificity, highest dose
Key: SPECT-CT bridges the gap between the low-cost whole-body planar bone scan and the expensive high-resolution PET-CT
Critical Must-Knows
- SPECT acquires 3D nuclear medicine data (like CT does for X-rays), providing volumetric functional information compared to the 2D planar bone scan.
- SPECT-CT combines SPECT functional data with CT anatomical data through co-registration — localising the metabolic abnormality to a specific anatomical structure.
- SPECT-CT adds diagnostic value in approximately 30% of cases over planar bone scan, often changing the clinical management.
- Key orthopaedic applications: painful arthroplasty evaluation, patellofemoral assessment, spinal fusion assessment, facet joint disease localisation, and stress fracture detection.
- SPECT-CT is particularly valuable when the planar bone scan shows uptake in a complex anatomical region (spine, wrist, foot) where precise localisation is needed.
Clinical Pearls
- "SPECT provides better contrast resolution and sensitivity than planar bone scan — it detects lesions that are invisible on the planar study.
- "The CT component serves dual purposes: attenuation correction (improving SPECT accuracy) and anatomical localisation of uptake.
- "In painful total knee replacement, SPECT-CT can differentiate patellofemoral from tibiofemoral sources of uptake — guiding targeted revision.
- "For spinal fusion assessment, SPECT-CT can confirm whether a fusion is solid (no uptake) or actively remodelling/pseudarthrosis (focal uptake at the fusion site).
- "SPECT-CT dose is higher than planar bone scan alone due to the CT component (typically 3-10 mSv additional).
Clinical Warning
SPECT-CT is examined in the context of specific clinical indications where its hybrid nature adds diagnostic value. You must understand: how SPECT differs from planar bone scan (3D vs 2D), why the CT component is essential (anatomical localisation and attenuation correction), and the specific orthopaedic applications — particularly painful arthroplasty, spinal fusion assessment, and stress fracture localisation. A common viva question involves explaining when SPECT-CT changes management compared to planar bone scan alone.
FOCUSSPECT-CT Advantages
| F | Functional data in 3D SPECT provides volumetric 3D functional data, detecting lesions with 20-30% better contrast than planar scanning |
| O | Overlay with CT anatomy Co-registration of SPECT and CT precisely localises the metabolic abnormality to a specific anatomical structure |
| C | Characterise the abnormality CT component shows the structural correlate (arthritis, fracture, hardware loosening) of the functional uptake |
| U | Upgraded diagnosis (30% of cases) SPECT-CT changes the diagnosis or management in approximately 30% of cases compared to planar bone scan alone |
| S | Specific localisation in complex regions Critical for the spine, wrist, foot, and around prostheses — where planar bone scan cannot distinguish adjacent structures |
| F | Functional data in 3D SPECT provides volumetric 3D functional data, detecting lesions with 20-30% better contrast than planar scanning | U | Upgraded diagnosis (30% of cases) SPECT-CT changes the diagnosis or management in approximately 30% of cases compared to planar bone scan alone |
| O | Overlay with CT anatomy Co-registration of SPECT and CT precisely localises the metabolic abnormality to a specific anatomical structure | S | Specific localisation in complex regions Critical for the spine, wrist, foot, and around prostheses — where planar bone scan cannot distinguish adjacent structures |
| C | Characterise the abnormality CT component shows the structural correlate (arthritis, fracture, hardware loosening) of the functional uptake |
Hook:FOCUS: SPECT-CT focuses the functional information onto the precise anatomical source — essential when planar scan is non-specific.
PSFATKey Orthopaedic SPECT-CT Indications
| P | Painful prosthesis evaluation Localises uptake to specific prosthetic interfaces (tibial, femoral, patellar) — guides targeted revision surgery |
| S | Spinal fusion assessment Determines whether a fusion segment has achieved solid union (no uptake) or has pseudarthrosis (active uptake) |
| F | Facet joint disease localisation Identifies the specific facet joint(s) responsible for back pain — guides diagnostic blocks and radiofrequency ablation |
| A | Arthritis characterisation Differentiates patellofemoral from tibiofemoral compartment disease. Identifies the pain-generating compartment |
| T | Tarsal and carpal pathology Localises uptake to specific small bones in the foot (navicular stress fracture) or wrist (scaphoid nonunion) |
| P | Painful prosthesis evaluation Localises uptake to specific prosthetic interfaces (tibial, femoral, patellar) — guides targeted revision surgery | A | Arthritis characterisation Differentiates patellofemoral from tibiofemoral compartment disease. Identifies the pain-generating compartment |
| S | Spinal fusion assessment Determines whether a fusion segment has achieved solid union (no uptake) or has pseudarthrosis (active uptake) | T | Tarsal and carpal pathology Localises uptake to specific small bones in the foot (navicular stress fracture) or wrist (scaphoid nonunion) |
| F | Facet joint disease localisation Identifies the specific facet joint(s) responsible for back pain — guides diagnostic blocks and radiofrequency ablation |
Hook:PSFAT: the five key applications where SPECT-CT adds value beyond planar bone scan.
RALSPECT-CT Technology
| R | Rotating gamma camera SPECT uses a rotating gamma camera that acquires data from multiple angles (120-360 degrees) to reconstruct a 3D volume |
| A | Attenuation correction by CT The CT scan corrects for tissue attenuation differences, improving SPECT quantitative accuracy — particularly important around metal implants |
| L | Localisation by co-registration SPECT and CT images are acquired sequentially on the same gantry, ensuring precise co-registration without requiring patient repositioning |
| R | Rotating gamma camera SPECT uses a rotating gamma camera that acquires data from multiple angles (120-360 degrees) to reconstruct a 3D volume |
| A | Attenuation correction by CT The CT scan corrects for tissue attenuation differences, improving SPECT quantitative accuracy — particularly important around metal implants |
| L | Localisation by co-registration SPECT and CT images are acquired sequentially on the same gantry, ensuring precise co-registration without requiring patient repositioning |
Hook:RAL: Rotating camera for 3D, Attenuation correction for accuracy, Localisation to anatomy.
Overview
SPECT-CT (Single Photon Emission Computed Tomography combined with Computed Tomography) is a hybrid imaging modality that combines the functional sensitivity of nuclear medicine with the anatomical precision of CT. This combination has become increasingly valuable in orthopaedic practice, particularly for solving diagnostic problems where planar bone scan provides insufficient anatomical localisation.
The fundamental principle is straightforward: planar bone scan tells you there is increased bone turnover somewhere in a region, but in anatomically complex areas (spine, wrist, tarsus, around prostheses), it cannot localise the uptake to a specific structure. SPECT-CT resolves this limitation by: (1) acquiring 3D nuclear medicine data (SPECT) with better contrast resolution than 2D planar imaging, and (2) co-registering this functional data with a CT scan that provides the anatomical framework.
When SPECT-CT Adds Value
SPECT-CT is most valuable when: (1) Planar bone scan shows uptake in a complex anatomical region where the source structure cannot be identified. (2) Evaluation of painful arthroplasty where precise compartmental localisation guides surgical planning. (3) Spinal fusion assessment where the question is whether a fusion is solid. (4) Back pain workup to identify the specific facet joint responsible. (5) Stress fracture localisation in complex anatomy (tarsal navicular, carpal bones). Studies show SPECT-CT changes the diagnosis in approximately 30% of cases and changes management in approximately 25%.
Limitations of SPECT-CT
SPECT-CT has lower spatial resolution than dedicated diagnostic CT or MRI (SPECT resolution approximately 7-10mm). The CT component is typically low-dose and is NOT equivalent to a diagnostic CT scan — it is primarily for localisation and attenuation correction. The additional radiation from the CT component (typically 3-10 mSv) must be justified by the clinical need. SPECT-CT is regional (not whole-body like planar scan), requiring the operator to select the region of interest. Availability is more limited than standard planar bone scan.
Clinical Imaging
Imaging Gallery
Systematic Approach
Systematic SPECT-CT Interpretation
SPECT-CT Interpretation Framework
| Step | Assessment | Key Principles |
|---|---|---|
| 1. Correlation with planar study | Compare SPECT-CT findings with the whole-body planar bone scan | SPECT-CT is regional — the planar study ensures no significant distant findings are missed |
| 2. SPECT data assessment | Assess 3D uptake patterns: location, intensity, distribution | SPECT provides better contrast than planar — it may reveal additional lesions not seen on the 2D study |
| 3. CT anatomical review | Review the CT component for structural correlates | Look for arthritis, fracture lines, hardware position, lytic/blastic lesions, soft tissue changes |
| 4. Fusion image analysis | Analyse the co-registered SPECT/CT fusion images | Determine which specific anatomical structure the SPECT uptake localises to — this is the key diagnostic step |
| 5. Clinical correlation | Integrate findings with clinical history, examination, and other imaging | Consider whether the SPECT-CT findings explain the patient's symptoms and guide management |
| 6. Management impact | Assess whether SPECT-CT changes or confirms the diagnosis and management plan | Document how SPECT-CT adds value — this justifies the additional radiation dose |
Clinical Applications
SPECT-CT for Painful Prosthesis
One of the most valuable orthopaedic applications of SPECT-CT is the assessment of painful total joint replacements, particularly total knee replacements (TKR).
The clinical problem: After TKR, approximately 15-20% of patients experience persistent pain. The source of pain may be patellofemoral maltracking, component malalignment, tibial or femoral component loosening, or soft tissue impingement. Planar bone scan often shows generalised periarticular uptake that cannot differentiate these sources.
SPECT-CT contribution: By co-registering the 3D uptake data with CT anatomy, SPECT-CT can localise uptake to: (1) the patellofemoral compartment (suggesting patellar maltracking or patella button loosening), (2) the tibial tray (suggesting tibial loosening or tibial component malalignment), (3) the femoral component (suggesting femoral loosening), or (4) specific soft tissue structures. This compartmental localisation directly guides targeted revision — for example, if SPECT-CT shows isolated patellofemoral uptake, an isolated patellar revision or lateral release may be appropriate rather than a full revision.
CT component assessment: In TKR evaluation, the CT also provides: (1) component alignment assessment (rotation, valgus/varus), (2) evidence of osteolysis, (3) cement mantle integrity, (4) implant position relative to the mechanical axis. Combined with the metabolic SPECT data, this gives a comprehensive functional-anatomical assessment.
Normal periprosthetic uptake can persist for 1-2 years post-surgery — SPECT-CT at less than 2 years must be interpreted with caution.
The Painful Prosthesis — Differentiating the Causes
The single highest-yield exam application is the painful arthroplasty. SPECT/CT helps separate the causes of periprosthetic pain, but its central limitation is that it cannot reliably distinguish septic from aseptic loosening — infection must always be excluded first by aspiration and inflammatory markers.
Differential of the Painful Knee/Hip Arthroplasty on SPECT/CT
| Cause | Typical SPECT/CT Pattern | Discriminating Feature |
|---|---|---|
| Aseptic component loosening | Focal bone-tracer uptake at the bone-implant or bone-cement interface, often with a corresponding lucent zone on CT | Interface-localised uptake plus CT lucency; normal inflammatory markers |
| Periprosthetic joint infection | Diffuse or interface uptake — overlaps with aseptic loosening and cannot be reliably separated | Cannot be excluded by SPECT/CT; needs aspiration, CRP/ESR, alpha-defensin, cultures |
| Patellofemoral overload / maltracking | Uptake localised to the patella or trochlea; CT shows malrotation or lateral tracking | Compartment-specific uptake guiding isolated patellar intervention |
| Component malalignment / overload | Uptake at the loaded condyle or tibial plateau matching CT-measured malrotation or varus/valgus | Uptake corresponds to the mechanically overloaded zone |
| Instability | Diffuse low-grade uptake, sometimes ligament insertion sites; CT may be near-normal | Pattern is non-specific — diagnosis is clinical and stress-radiographic |
| Extra-articular / referred pain | Little or no significant periprosthetic uptake | Negative SPECT/CT redirects the search (spine, vascular, neuropathic) |
Infection Cannot Be Excluded by SPECT/CT
A focal interface uptake on SPECT/CT does NOT differentiate aseptic loosening from periprosthetic joint infection. In any painful arthroplasty you must exclude infection first with inflammatory markers (CRP, ESR), joint aspiration for cell count, differential and culture, and adjuncts such as alpha-defensin where available. Reserve SPECT/CT for characterising the aseptic, non-infected painful joint.
Controversies & Areas of Uncertainty
Lack of Standardised Thresholds
There is no universally agreed quantitative cut-off for "abnormal" bone-tracer uptake on SPECT/CT. Most reporting remains semi-quantitative (visual colour-coded grading such as the Hirschmann scheme). Quantitative SPECT/CT (SUV-like metrics) is emerging but not yet standardised across vendors, limiting reproducibility between centres.
Radiation Dose Justification
The CT component adds dose (commonly an additional few mSv, varying with protocol and coverage). In young athletes with spondylolysis this is a genuine concern, and several guidelines favour radiograph-then-MRI pathways first. The debate is where SPECT/CT sits in the algorithm versus low-dose CT or MRI alone.
Septic vs Aseptic Loosening
SPECT/CT cannot reliably separate infection from aseptic loosening. Whether newer tracers, white-cell SPECT/CT, or FDG-PET/CT should be preferred for suspected periprosthetic infection remains an active area, and practice varies by available infrastructure.
Evidence Quality
Much of the orthopaedic SPECT/CT literature is retrospective single-centre cohorts with modest specificity and no blinded outcome arm. The strongest data are diagnostic-test-accuracy meta-analyses for the painful knee; large prospective management-impact trials are still lacking.
Evidence Base
SPECT/CT for the Painful Non-Infected Knee Arthroplasty (Meta-analysis)
- Pooled across 8 studies and 308 patients, SPECT/CT had a pooled sensitivity of 0.86 (95% CI 0.75-0.93) and specificity of 0.90 (95% CI 0.79-0.96) for identifying the source of pain in non-infected painful knee arthroplasty.
- Pooled positive likelihood ratio was 8.9 and negative likelihood ratio 0.15, with an area under the curve of 0.94 and diagnostic odds ratio of 57.
- SPECT/CT accurately identified loosening, patellofemoral overloading, instability, and component malalignment; GRADE certainty of evidence was moderate (level III).
Standardised SPECT/CT Algorithm for Painful TKA
- Introduced a standardised SPECT/CT localisation scheme of 9 tibial, 9 femoral and 4 patellar regions, piloted in 18 consecutive patients with pain after TKA.
- The scheme demonstrated very high inter- and intra-observer reliability for both anatomical localisation and tracer-activity grading.
- Median inter-observer difference for tibial and femoral component alignment measurement was less than 3 degrees, combining metabolic (tracer) and biomechanical (CT alignment) data.
SPECT-CT reliably localises and characterises the source of pain after arthroplasty.
Guidelines, Registries & Global Practice
SPECT/CT is now a mainstream problem-solving tool in skeletal nuclear medicine worldwide, but it is not the first-line skeletal study anywhere — it is deployed selectively after a planar bone scan, radiograph or cross-sectional study leaves a specific question unanswered. There is no dedicated implant registry for an imaging test, so the evidence base is built from single-centre cohorts and the diagnostic-test-accuracy meta-analyses cited above rather than registry survivorship data.
Global Epidemiology and Demand Drivers
- Demand is driven by the rising prevalence of joint arthroplasty (the painful TKR/THR workup), an ageing degenerative spine population (facet and pseudarthrosis assessment) and youth sport (active spondylolysis).
- Approximately 10-20% of patients report persistent pain after total knee arthroplasty, generating a large referral pool in which SPECT/CT localises a source in the majority of non-infected cases.
- Tc-99m diphosphonate remains the universal bone tracer; access to SPECT/CT hardware, not tracer supply, is the main determinant of availability between regions.
Society Guidance, Side by Side
How Major Bodies Position SPECT/CT
| Body | Stance on SPECT/CT | Practical Emphasis |
|---|---|---|
| EANM (European Association of Nuclear Medicine) | Procedure guidelines endorse SPECT/CT for bone imaging where anatomical localisation or attenuation correction adds value | Standardised acquisition, low-dose CT protocols, attenuation correction around metalwork |
| SNMMI (Society of Nuclear Medicine and Molecular Imaging, US) | Recognises SPECT/CT as adding localisation and specificity over planar and SPECT alone | Appropriate-use framing — perform when it will change the report or management |
| EFORT / national orthopaedic societies | Position SPECT/CT within the painful-arthroplasty and spine algorithms after infection has been excluded | Aspiration and inflammatory markers first for the painful prosthesis; SPECT/CT for aseptic problem-solving |
| AAOS / general radiology bodies (ACR) | MRI and CT remain first-line for most musculoskeletal problems; nuclear medicine is adjunctive | Reserve hybrid nuclear imaging for equivocal cases or metal-artifact-limited MRI |
| IOC / sports-medicine consensus | Favour low-radiation pathways (radiograph then MRI) in young athletes; SPECT/CT for activity grading when needed | Minimise dose in adolescents; use SPECT only when healing potential must be established |
High- vs Limited-Resource Practice Variation
- Well-resourced centres: Hybrid SPECT/CT cameras are standard; the question is appropriate use and dose optimisation, not access. Quantitative SPECT/CT and cadmium-zinc-telluride detectors are emerging to improve resolution and lower dose.
- Limited-resource settings: Many departments still run planar gamma cameras or stand-alone SPECT without an integrated CT. Here, planar bone scan plus separately acquired CT/MRI, or careful clinical-radiographic correlation, substitutes for hybrid imaging. The diagnostic question is the same; the answer is reached with less elegant co-registration and sometimes higher cumulative dose.
- Across all settings the governing principle is justification and optimisation (the ALARA principle): the additional CT dose must be offset by a genuine change in the report or management, exactly as the cited cohorts demonstrate.
Clinical Decision Scenarios
Use these scenarios to practise clinical reasoning and management decisions
"A 55-year-old patient presents with anterior knee pain 3 years after total knee replacement. A planar bone scan shows diffuse periarticular uptake around the TKR. You are asked about the role of SPECT-CT."
"A 16-year-old cricket fast bowler presents with persistent low back pain. MRI shows bilateral pars defects at L5 but is equivocal for marrow oedema. How would SPECT-CT help?"
"An examiner asks you to compare SPECT-CT, PET-CT, and planar bone scan for orthopaedic applications."
SPECT-CT Applications — Exam Day Reference
Clinical summary
SPECT-CT Basics
- •SPECT: 3D nuclear medicine data (rotating gamma camera)
- •CT: anatomical co-registration + attenuation correction
- •Fusion: precise localisation of metabolic activity to anatomy
- •Changes diagnosis in approximately 30% of cases over planar scan
Key Indications (PSFAT)
- •Painful prosthesis (TKR compartmental localisation)
- •Spinal fusion (solid vs pseudarthrosis)
- •Facet joint disease (identifies the pain-generating level)
- •Arthritis (patellofemoral vs tibiofemoral compartment)
- •Tarsal/carpal pathology (specific bone localisation)
Painful TKR Workup
- •Normal postoperative uptake resolves by 1-2 years
- •SPECT-CT localises to patellofemoral vs tibiofemoral compartment
- •CT assesses alignment, osteolysis, cement mantle
- •CANNOT exclude infection — always aspirate the joint
Spondylolysis Assessment
- •SPECT active = healable with bracing (sensitivity 97%)
- •SPECT inactive = established non-union (bracing unlikely to heal)
- •CT shows structural defect status (gap, sclerosis, callus)
- •Critical for management decisions in young athletes
Comparison with Other Modalities
- •Planar bone scan: 2D screening (whole-body, cheap, low dose)
- •SPECT-CT: 3D problem-solver (regional, moderate dose)
- •PET-CT: comprehensive stager (highest resolution, highest dose, detects lytic)